Stearns Financial Services Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-740
Closed -$223K 171
2018
Q4
$223K Hold
740
0.05% 118
2018
Q3
$261K Sell
740
-104
-12% -$35.8K 0.06% 110
2018
Q2
$245K Hold
844
0.06% 113
2018
Q1
$231K Buy
844
+11
+1% +$3.42K 0.06% 116
2017
Q4
$265K Sell
833
-57
-6% -$18.3K 0.06% 110
2017
Q3
$279K Sell
890
-114
-11% -$33.8K 0.07% 104
2017
Q2
$272K Buy
1,004
+173
+21% +$45.7K 0.07% 113
2017
Q1
$227K Buy
831
+90
+12% +$25.4K 0.06% 121
2016
Q4
$210K Buy
+741
New +$220K 0.05% 122

Other funds holding BIIB

Stearns Financial Services Group's BIIB Position: Q1 2019 in Review

Stearns Financial Services Group sold out of Biogen (BIIB) in Q1 2019, closing a stake of 740 shares — an estimated $223K sold.

Stearns Financial Services Group first reported a position in BIIB in Q4 2016 and held it in 9 quarters. The position peaked at $279K in Q3 2017. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Stearns Financial Services Group reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Stearns Financial Services Group sold 740 Biogen shares in Q1 2019, an estimated $223K.
  • Stearns Financial Services Group first reported a position in Biogen in Q4 2016 and held it in 9 quarters.
  • Stearns Financial Services Group's Biogen position peaked at $279K in Q3 2017.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Stearns Financial Services Group's 13F filing for Q1 2019, filed 15 May 2019.